SciELO - Scientific Electronic Library Online

 
vol.27 issue8Positron emission tomography (PET) in oncological clinical practiceCD44v6 expression in lung squamous carcinoma: Association with elevated concentrations of EGFR, erbB2 protein and high cell proliferation author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Oncología (Barcelona)

Print version ISSN 0378-4835

Abstract

BOSCH ROIG, C. et al. Colorectal adenocarcinoma: survival prognostic factors of the adjuvant treatment with 5-fluorouracil-levamisole (5FU-Lev). Oncología (Barc.) [online]. 2004, vol.27, n.8, pp.26-34. ISSN 0378-4835.

PURPOSE: To assess the overall survival and the 5-year disease-free survival, and to investigate the prognostic factors of patients with stages II and III colorectal adenocarcinoma subjected to healing-intention surgery and adjuvant chemotherapy with 5-fluorouracil-levamisole (5-FU-LEV). MATERIAL AND METHODS: A cohort of 126 patients treated with 5-FU-LEV during 12 months were studied between September 1990 and November 1997. RESULTS: The number of infiltrated lymph nodes, and the vascular-lymphatic and perineural invasion were found to be significant prognostic factors in the mean overall survival and disease-free survival after 5 years. Bowel obstruction showed prognostic significance only in relation to the 5-year disease-free survival. CONCLUSIONS: The obtained results are similar to those reported in other large series published in the literature related with overall survival, disease-free survival and prognostic factors. Infiltrated lymph nodes remain as a significant prognostic factor in multivariate analysis.

Keywords : Colon cancer; Rectal cancer; Adjuvant chemotherapy; Prognosis study.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License